Company Overview and News

82
Dow 30 Stock Roundup: JPMorgan Ups Dividend, Disney's ESPN+ Hits 1M Paid Subscribers

23h zacks
The index made strong gains this week as investors shrugged off trade tensions. Trump’s decision to impose fresh tariffs on $200 billion of Chinese imports did weigh on investors. But the recent raft of positive economic data helped investors focus on broader fundamentals. Financials gained after yields on U.S. government bonds surged substantially. Tech majors also defied tariff worries to post strong gains.
BAC GS GLSSP DIS JBK BAC PFZ C GSC TFG MA PFIZER GSJ V MSFT GJS 500680 PFE

2
Mastercard, Inc. (MA) Management Presents at Autonomous Future of Commerce Symposium Conference (Transcript)

2018-09-20 seekingalpha
So we are going to get started, again. For those joining us on the webcast, again, I’m Craig Maurer of Anonymous. I run the Payments team here. We are lucky today to have Craig Vosburg from Mastercard. He is President of North America for the company. Thanks for joining us.
MA

9
This Is What Disruption Looks Like: The Coming Shakeout In Transaction Banking

2018-09-19 seekingalpha
All kinds of banks (global banks, local banks, investment banks) could be piling into the transaction banking business.
V MA

2
Mastercard's (MA) Tie-Up to Digitalize Global B2B Market

2018-09-19 zacks
Mastercard Incorporated (MA - Free Report) and JAGGAER have entered into a partnership to jointly launch Mastercard Track, a new trade platform designed to streamline and boost its global commercial business interactions. This new platform targets the international B2B (Business to Business) market, which still works manually and incurs around $500 billion of annual administrative expenses. Track is powered by an array of Mastercard innovation and B2B assets, such as account-to-account and card payment solutions, data analytics, fraud management, payment gateway services, etc.
UNP MA WEX CATM EVTC

14
Visa (V), Mastercard to Settle U.S. Merchant Litigation

2018-09-19 zacks
Visa Inc. (V - Free Report) , Mastercard Incorporated (MA - Free Report) , along with banks including JPMorgan Chase & Co. (JPM - Free Report) , Citigroup Inc. (C - Free Report) and Bank of America Corp. would pay merchants about $6.5 billion on account of Payment Card Interchange Fee and Merchant Discount Antitrust Litigation.
C UNP MA V CGBBW

19
Wall Street rebounds in the face of heated trade row

2018-09-19 thehindubusinessline
Apple Inc shares were up 0.7 per cent after Chief Executive Tim Cook expressed optimism that the US-China trade dispute will be amicably settled.
GIS FIT V NKE BOE AAPL MA BA

67
15 Best S&P 500 Stocks to Buy as the Markets Heat Up

2018-09-19 investorplace - 1
One of the more popular strategies among investors today is to seek out “home runs.” These are lesser-known companies that have tremendous upside potential, but carry the risk of collapsing should business prospects go awry. While a balanced portfolio allows for some speculation, now is also a great time to consider S&P 500 stocks.
LMT HD EA FB UPS MA DRI FDX BBY HOG GT V AMZN CVX RTN ABBV HPQ MO

85
10 Best Blue-Chip Stocks for Mid-Career Investors

2018-09-19 investorplace - 2
Workers in their 30s and 40s often find themselves in tricky situations, career-wise. They’re certainly beyond their trainee days, but not yet in positions only awarded to employees with a wealth of experience and proven acumen. It’s in this time of life when workers find themselves on a clear path to some sort of senior position, or realize it’s just not going to happen.
QRVO MA PYPL AMD NVDA WMT ADBE AMZN AMT MRK GOOGL MSFT CAH INTC

19
Wall Street rebounds in the face of heated trade row

2018-09-18 reuters
NEW YORK (Reuters) - Wall Street bounced back on Tuesday, led by gains in consumer discretionary, technology and industrial stocks as investors shrugged off escalating trade rhetoric between the United States and China.
GIS FIT V NKE BOE AAPL MA BA

21
Visa, Mastercard reach $6.2 billion settlement on swipe fees

2018-09-18 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
C MA V CGBBW SBUX

15
Visa, Mastercard reach US$6.2b settlement over card-swipe fees

2018-09-18 theedgemarkets
NEW YORK (Sept 18): Visa Inc, Mastercard Inc, and a number of US banks on Tuesday agreed to pay US$6.2 billion to settle a long-running lawsuit brought by merchants over the fees they pay when they accept card payments.
V COST MA

9
Visa, Mastercard reach $6.2 bln settlement over card-swipe fees

2018-09-18 reuters
Sept 18 (Reuters) - Visa Inc, Mastercard Inc, and a number of banks on Tuesday agreed to pay $6.2 billion to settle a long-running lawsuit brought by merchants over the fees they pay when they accept card payments.
V MA

9
Visa, Mastercard reach $6.2 billion settlement over card-swipe fees

2018-09-18 reuters
(Reuters) - Visa Inc (V.N), Mastercard Inc (MA.N), and a number of banks on Tuesday agreed to pay $6.2 billion to settle a long-running lawsuit brought by merchants over the fees they pay when they accept card payments.
V MA

9
Visa, Mastercard reach US$6.2 billion settlement over card-swipe fees

2018-09-18 channelnewsasia
Visa Inc , Mastercard Inc , and a number of banks on Tuesday agreed to pay US$6.2 billion to settle a long-running lawsuit brought by merchants over the fees they pay when they accept card payments.
V MA

12
Market Snapshot: Stock futures edge up, but trade uncertainty remains in focus

2018-09-18 marketwatch
U.S. stock-index futures were slightly higher on Tuesday, though investors continued to monitor the latest development on the trade-policy front, which has recently shown signs of escalating.
GIS V AZO OCLCF MA ORCL

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to MA / MasterCard Incorporated on message board site Silicon Investor.

Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Mainstream Politics and Economics Mainstream Politics and Economics Mainstream Politics and Economics
The Zenyatta Information Board The Zenyatta Information Board The Zenyatta Information Board Kirku0027s Market Thoughts Kirku0027s Market Thoughts Kirku0027s Market Thoughts
International Automated Systems International Automated Systems International Automated Systems Technology Stocks u0026 Market Talk With Don Wolanchuk Technology Stocks u0026 Market Talk With Don Wolanchuk Technology Stocks u0026 Market Talk With Don Wolanchuk
Market Thoughts and Trades Market Thoughts and Trades Market Thoughts and Trades John Pu0027s Market Laboratory John Pu0027s Market Laboratory John Pu0027s Market Laboratory
Marijuana Stocks Marijuana Stocks Marijuana Stocks TNRG Tianrong Building Materials TNRG Tianrong Building Materials TNRG Tianrong Building Materials
CUSIP: 57636Q104